Philips Respironics, a unit of Royal Philips, has announced the launch of new gel pillows mask for the sleep apnea patients. The company has launched Nuance, a light and airy nasal gel pillows mask. Nuance gel pillows represents the new ...
Tags: Philips, Gel Pillows Mask
Nyxoah, a Belgian-Israeli start-up company, has announced that the US Patent and Trademark Office (USPTO) is issuing 11 patents for Nyxoah's obstructive sleep apnea technology. The first eight granted patents were published today on the ...
Tags: Apnea Technology, Medicine
US-based Respicardia has unveiled six month results from the remede system pilot study, the first prospective, multi-center, global trial to treat central sleep apnea (CSA). The remede system delivers electrical pulses to one of the ...
Tags: Respicardia, Remede System
Circadiance, a manufacturer of respiratory products, has introduced the SleepWeaver Anew soft cloth full face PAP mask, designed for continuous positive airway pressure (CPAP) users who breathe through their mouth while sleeping. The ...
Two congressmen have introduced bipartisan legislation that would require the Federal Motor Carrier Safety Administration to write a regulation covering sleep disorders, rather than issue a guidance as it is planning to do. Reps. Larry ...
Tags: Light Industry, Daily Use, sleep products
Both the American Trucking Associations (ATA) and Owner-Operator Independent Drivers Association (OOIDA) are supporting new legislation that will require the US government to follow the established rulemaking process when introducing ...
Tags: Transportation, truck
ResMed, a developer of medical equipment for respiratory disorders, has enrolled 1,325 patients in SERVE-HF, an international, randomized study designed to determine sleep-disordered breathing in heart failure patients. The study will ...
Tags: ResMed, Serve-HF Study
Respicardia, a US-based developer of implantable therapies, has announced the enrollment of the first patients in the pivotal trial to evaluate the remede system in patients with central sleep apnea (CSA). The Respicardia pivotal trial is ...
Tags: Respicardia, Patient Enrollment
Lupin Pharmaceuticals has gained tentative FDA approvals for Armodafinil tablets, 50mg, 100mg, 150mg, 200mg and 250mg strengths in addition to Doxycycline capsules, 40mg (30mg immediate-release and 10mg delayed-release). Armodafinil ...
Zynex, a provider and developer of non-invasive medical devices for electrotherapy and stroke rehabilitation, neurological diagnostics and cardiac monitoring, has inked a strategic sales, marketing and distribution agreement with US-based ...
Perhaps prompted by all the ads for drugs such as AndroGel 1.62% and Axiron, many men attribute their lagging libido to reduced testosterone levels. But stress, depression, lack of sleep or exercise, work load, or changed feelings about ...
Tags: Low-T, Health&Medicine
Respicardia, a US-based implantable therapies developer, has received approval from the US Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) to begin the pivotal trial of remedē System. The trial will ...
Tags: Respicardia, therapies developer
Parmar Family and Cosmetic Dentistry, a US-based dental care provider, has launched quick and convenient clear braces for adults. Six Month Smiles invisible braces complete treatment in six months time period compared to the typical ...
Tags: Parmar Dentistry, Parmar, Dentistry
Cook Medical, a US-based developer of health care devices, has introduced salivary duct access products to treat sialolithiasis, defined as obstruction by salivary duct stones. Designed as alternative to open surgery, the devices are used ...
Tags: Cook Medical, Medical, health care devices
The US Food and Drug Administration (FDA) has granted approval to Medtronic's AIRvance Bone Screw System. The approval allows surgeons to perform a hyoid suspension procedure independently or in combination with other procedures including ...